retatrutide weight loss phase 2 trial results Eli Lilly's shows promising in 3 Phase III retatrutide study demonstrates

Ferumoxytol Injection by Sandoz is a high-potency intravenous iron replacement medication, supplied as a 30 mg/mL solution in a convenient 17 mL single-dose vial

Nano lipid carriers as a promising drug delivery carrier for neurodegenerative disorders - an overview of recent advances

"I had an awareness of [weight loss] medications [before], but felt I had to prove I had the willpower to do it

The combination of these peptides within a single preparation allows researchers to explore comparative peptide behaviour and interaction dynamics in controlled experimental models

#1573 Effects of haemodialysis coupled with hemadsorption on uremic toxins removal, oxidative stress and cellular death

Influence of somatostatin (SS-14) on early dumping reaction in patients after partial gastrectomy [German]